- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00985335
Effectiveness of TheraNeem Lip Therapy for Herpes Simplex Labialis (Neem)
November 16, 2011 updated by: Sivarama Vinjamury, Southern California University of Health Sciences
Effectiveness of TheraNeem Lip Therapy of Common Symptoms of Herpes Simplex Labialis A Prospective Experimental Case Series (n=5)
This study intends to test the efficacy of the TheraNeem Lip Therapy balm for Herpes Simplex.
The study will include a total of 5 people.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Qualified candidates will be officially enrolled into the study within 24 hours of their subsequent outbreak of Herpes Simplex Labialis.
They will be given all of the Neem Therapy products to use, and photographs and questionnaires will be taken to assess their progress.
Study Type
Interventional
Enrollment (Actual)
5
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Whittier, California, United States, 90604
- Southern California University of Health Science
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Participant has signs and symptoms of HSV-1 infection of less than 24 hours duration to the Southern California University of Health Sciences investigators
- Participants ages 18-70 years
- Confirmation of oral-circumoral herpes lesion will be made by a clinician in the presence of oral-circumoral lesion assumed to be HSV-1 for purposes of study
- Subjects expressed willingness to comply with protocol
- Subject will be willing to have the presenting lesion photographed twice
- Subject sign a written informed consent, HIPPA disclosure, Experimental bill of rights
Exclusion Criteria:
- History of past or present immunosuppressive condition, or currently taking immunosuppressive medication
- History of adverse effects or allergies to any Neem based product or containing any of the other ingredients TheraNeem Lip Therapy: Organic Coconut Oil, Organic Beeswax, Organic Jojoba Oil, Shea Butter, Sesame Oil, Organic Neem Oil, , Essential Oil of Peppermint, Vitamin E (Tocopherol)
- Signs of disseminated HSV illness
- History of use of oral or topical antiviral agents within 10 days of screening and/or at start of study visit
- Pregnancy or lactation
- Psychiatric disorder
- Inability to understand or follow the instructions
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: External Application of Neem-based Cream
Non Controlled, non-randomized, single group pilot study.
|
Apply externally 3-4 times per day
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Cold Sore Symptom Scale
Time Frame: Baseline and End of Treatment
|
Baseline and End of Treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Melany Meier, DC, Southern California University of Health Sciences
- Principal Investigator: Sivarama Vinjamury, L.Ac, Southern California University of Health Sciences
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2009
Primary Completion (Actual)
February 1, 2011
Study Completion (Actual)
March 1, 2011
Study Registration Dates
First Submitted
August 28, 2009
First Submitted That Met QC Criteria
September 25, 2009
First Posted (Estimate)
September 28, 2009
Study Record Updates
Last Update Posted (Estimate)
November 18, 2011
Last Update Submitted That Met QC Criteria
November 16, 2011
Last Verified
November 1, 2011
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SCU-09-VINJ004
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Herpes Simplex
-
Rigshospitalet, DenmarkUnknownHerpes Simplex I | Herpes Simplex II
-
University of Alabama at BirminghamWithdrawn
-
Global Research InstituteRational Vaccines IncRecruitingHIV Disease | Herpes Simplex 2 | Herpes Simplex 1United States
-
Genocea Biosciences, Inc.CompletedGenital Herpes Simplex Type 2United States
-
Leciel BonoRecruitingHSV-1 | Herpes Simplex Labialis | Virus | Herpes Simplex 1United States
-
New York State Psychiatric InstituteAlzheimer's AssociationActive, not recruitingMild Cognitive Impairment | Herpes Simplex 2 | Herpes Simplex 1United States
-
Genocea Biosciences, Inc.CompletedGenital Herpes Simplex Type 2United States
-
Genocea Biosciences, Inc.CompletedGenital Herpes Simplex Type 2United States
-
Nearmedic Plus LLCCompletedHerpes Simplex | Herpes Genitalis | Herpes | Herpes Oral | Herpes Simplex 2Russian Federation
-
University of Alabama at BirminghamCompleted
Clinical Trials on Neem Based External Application Cream
-
Medical University of SilesiaCompletedCannabis | Myofascial Pain | Temporomandibular Disorder | ElectromyographyPoland
-
Medical Entomology CentrePN Lee Statistics and Computing Ltd; Leeds Health Protection Unit; NelsonsCompleted
-
Hospices Civils de LyonNot yet recruitingHead and Neck Neoplasms | Carcinoma, Non-Small-Cell Lung | Colorectal NeoplasmsFrance
-
MemorialCare Health SystemNot yet recruitingPreeclampsia | Preeclampsia Postpartum | Preeclampsia Severe | Preeclampsia Mild
-
Novartis PharmaceuticalsTerminatedCutaneous Squamous Cell Carcinoma in Situ (CSCCis)Belgium, Australia, United States
-
University of ExtremaduraCompleted
-
Laboratoires FILLMEDCompleted
-
GlaxoSmithKlineCompletedDenture RetentionUnited States
-
Denver Health and Hospital AuthorityRecruitingCoronary Artery Disease | Percutaneous Coronary Intervention | Acute Myocardial Infarction | Chronic Stable Angina | Chronic Stable Heart Failure | Valvular DiseaseUnited States
-
Tuğba BilgehanEnrolling by invitation